Iovance Biotherapeutics
IOVA
IOVA
283 hedge funds and large institutions have $943M invested in Iovance Biotherapeutics in 2026 Q1 according to their latest regulatory filings, with 64 funds opening new positions, 120 increasing their positions, 58 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
8% more funds holding
Funds holding: 263 → 283 (+20)
4% more call options, than puts
Call options by funds: $15.1M | Put options by funds: $14.6M
0.6% less ownership
Funds ownership: 65.9% → 65.29% (-0.6%)
Holders
283
Holding in Top 10
3
Calls
$15.1M
Puts
$14.6M
Top Buyers
| 1 | +$29.7M | |
| 2 | +$13.4M | |
| 3 | +$9.05M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$7.53M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
+$7.29M |
Top Sellers
| 1 | -$20.8M | |
| 2 | -$18.5M | |
| 3 | -$11.1M | |
| 4 |
Morgan Stanley
New York
|
-$9.57M |
| 5 |
State Street
Boston,
Massachusetts
|
-$8.68M |
